Buscar
Resultados de la búsqueda
Select an image to start the slideshow
Part I. Design of a novel class of reversible non-covalent small
molecule inhibitors for human Granzyme B (hGrB)
Part II. Curcumin and mimics as proteasome inhibitors
Part III. Design of novel coactivator binding inhibitors (CBIs)
for the estrogen receptor α : break the 1µM barrier
1 of 9
Engineering The Substrate Specificity Of Human Deoxycytidine Kinase
2 of 9
Generating designer enzymes for therapeutic and industrial
applications
3 of 9
Development of Fluorescence-based Molecular Tension Probes to Investigate Cellular Mechanical Forces
4 of 9
Development of Monocarbonyl Curcumin Analogues Towards Treating
Tuberculosis and Cancer
5 of 9
Investigation of C-H Bond Oxidation Reactions: I. Asymmetric
Amination of C-H Bonds Using Ruthenium(II) Catalysts II.
Investigation of Structural Determinants of Monoamine Oxidase B
6 of 9
Part I: Structure and Function in the NMDA Ligand Binding DomainPart II: Comparison of Paclitaxel Analogs through MolecularDynamics Simulation; Solution Conformations of Cyclic Peptides
7 of 9
Paclitaxel and Cyclostreptin in theTubulin Binding Site
8 of 9
Part I: Measles virus entry into cells and the inhibition offusion and replicationPart II: The nature of cyclostreptin's interaction withmicrotubules
9 of 9